• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results

    2/22/24 2:56:29 PM ET
    $DPRO
    $GBNH
    $KDP
    $LRHC
    Aerospace
    Industrials
    Misc Health and Biotechnology Services
    Health Care
    Get the next $DPRO alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 400 points on Thursday.

    The Dow traded up 1.13% to 39,048.47 while the NASDAQ rose 2.93% to 16,037.52. The S&P 500 also rose, gaining, 2.08% to 5,085.62.

    Check This Out: Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

     

    Leading and Lagging Sectors

     

    Information technology shares rose by 4% on Thursday.

    In trading on Thursday, utilities shares fell by 0.4%.

     

    Top Headline

     

    Shares of Keurig Dr Pepper Inc. (NASDAQ:KDP) fell over 3% on Thursday after the company released results for its fourth quarter.

    Keurig reported fourth-quarter adjusted EPS of 55 cents, breezing past the analyst consensus of 54 cents. Quarterly revenues of $3.867 billion marginally missed the street view of $3.914 billion.

     

    Equities Trading UP

     

    La Rosa Holdings Corp. (NASDAQ:LRHC) shares shot up 101% to $2.82 after the company disclosed that it has acquired a 100% interest in the La Rosa Realty Winter Garden franchise in Florida.

    Shares of Root, Inc. (NASDAQ:ROOT) got a boost, surging 52% to $13.14 after the company reported better-than-expected fourth-quarter financial results. Following earnings, Cantor Fitzgerald upgraded the stock from Neutral to Overweight and raised its price target from $9 to $13.

    Monopar Therapeutics Inc. (NASDAQ:MNPR) shares were also up, gaining 67% to $0.9560 after the company announced preclinical data for its MNPR-101 radiopharma program targeting advanced cancers.

     

    Equities Trading DOWN

     

    Draganfly Inc. (NASDAQ:DPRO) shares dropped 50% to $0.1792 after the company announced pricing of $3.6 million underwritten public offering.

    Shares of Greenbrook TMS Inc. (NASDAQ:GBNH) were down 46% to $0.2079 after the company announced a $1.2 million registered direct offering of 6 million shares at $0.20 per share purchase price.

    Rivian Automotive, Inc. (NASDAQ:RIVN) was down, falling 26% to $11.39 after the company reported a wider-than-expected loss for its fourth quarter and announced plans to reduce its salaried workforce by around 10% to help further improve costs. The company said it sees production of 57,000 vehicles in 2024.

    Also Check This Out: Jim Cramer: Unity Software 'Had Problems,' But Zscaler Is A 'Good One' To Buy

     

    Commodities

     

    In commodity news, oil traded up 1.1% to $78.73 while gold traded down 0.1% at $2,032.40.

    Silver traded down 0.4% to $22.795 on Thursday while copper rose 0.5% to $3.8945.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 climbed 0.82%, London’s FTSE 100 rose 0.29% while Spain’s IBEX 35 Index rose 0.31% The German DAX gained 1.47% French CAC 40 rose 1.27% while Italy’s FTSE MIB Index rose 1.06%.

    The inflation rate in the Eurozone eased to 2.8% in January from 2.9% in December. The HCOB Eurozone manufacturing PMI fell to 46.1 in February from 46.6 in January, while services PMI rose to 50 in February. The HCOB France composite PMI rose to 47.7 in February from 44.6 in the earlier month, while German composite PMI fell to 46.1 in February from 47.0 in the prior month.

    The S&P Global UK services PMI came in steady at 54.3 in February, while manufacturing PMI rose to 47.1 in February from 47 in January.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Wednesday, with Japan’s Nikkei 225 surging 2.19%, Hong Kong’s Hang Seng Index rising 1.45%, China’s Shanghai Composite Index gaining 1.27% and India’s S&P BSE Sensex jumping 0.74%.

    The annual inflation rate in Hong Kong eased to 1.7% in January from 2.4% in the prior month. The HSBC India composite PMI rose to 61.5 in February from a final reading of 61.2 in the earlier month. The au Jibun Bank Japan composite PMI declined to 50.3 in February versus a final reading of 51.5 in January.

     

    Economics

     

    The Chicago Fed National Activity Index fell to -0.30 in January versus a revised reading of 0.02 in the previous month.

    U.S. initial jobless claims fell by 12,000 to 201,000 in the week ending Feb. 17, compared to market estimates of 218,000.

    The S&P Global Flash manufacturing PMI climbed to 51.5 in February from 50.7 in January, while services PMI fell to 51.3 in February from 52.5.

    The S&P Global composite PMI fell to 51.4 in February from 52 in the prior month.

    Crude oil inventories increased by 3.514 million barrels in the week ending Feb. 16, 2024, compared to market estimates of a 3.879 million rise.

    U.S. natural-gas supplies fell 60 billion cubic feet during the week ended Feb. 16, 2024.

    Existing-home sales in the U.S. climbed 3.1% month-over-month to an annualized rate of 4 million units in January.

    Now Read This: Starbucks, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling

    Get the next $DPRO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DPRO
    $GBNH
    $KDP
    $LRHC

    CompanyDatePrice TargetRatingAnalyst
    Keurig Dr Pepper Inc.
    $KDP
    4/22/2026$28.00Underperform → Neutral
    BNP Paribas Exane
    Rivian Automotive Inc.
    $RIVN
    4/1/2026$14.00Underperform → Neutral
    DA Davidson
    Draganfly Inc.
    $DPRO
    3/25/2026$14.00 → $12.00Buy
    Needham
    Rivian Automotive Inc.
    $RIVN
    3/10/2026$20.00Hold → Buy
    TD Cowen
    Rivian Automotive Inc.
    $RIVN
    3/4/2026$14.00Underperform
    BofA Securities
    Rivian Automotive Inc.
    $RIVN
    2/17/2026$14.00Neutral → Underperform
    DA Davidson
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$23.00Hold → Buy
    Deutsche Bank
    Rivian Automotive Inc.
    $RIVN
    2/13/2026$16.00Sell → Neutral
    UBS
    More analyst ratings

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Flatley Jay T bought $25,281 worth of shares (1,830 units at $13.81) and sold $11,775 worth of shares (580 units at $20.30), increasing direct ownership by 0.78% to 162,070 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    3/5/26 5:10:12 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Large owner Hrt Financial Lp bought $15,605 worth of Class A Shares (14,584 units at $1.07) and sold $9,121 worth of Class A Shares (8,368 units at $1.09), increasing direct ownership by 15% to 48,596 units (SEC Form 4)

    4 - La Rosa Holdings Corp. (0001879403) (Issuer)

    3/3/26 2:57:47 PM ET
    $LRHC
    Real Estate
    Finance

    Chief Financial Officer Vu Quan Anh bought $104,925 worth of shares (1,500 units at $69.95) (SEC Form 4)

    4 - Monopar Therapeutics (0001645469) (Issuer)

    12/29/25 12:15:31 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Mcdonough Claire sold $184,410 worth of shares (10,245 units at $18.00) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 946,814 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    4/24/26 4:43:40 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Gomez Aidan N.

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    4/22/26 4:43:02 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by Schwartz Sanford Harold

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    4/22/26 4:42:15 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Root & Freeway Insurance Expand Integrated Coverage Options Through New Partnership

    COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- Root (NASDAQ:ROOT), the leading technology company in car insurance, and Freeway Insurance, the nation's largest personal lines insurance distribution platform, today announced a collaboration designed to expand customer access and enhance the overall insurance experience across Freeway's national network. Through this partnership, Root's technology and insurance products will be integrated into Freeway's multi-carrier marketplace, expanding the range of coverage options available to customers. This addition enhances Freeway's ability to deliver more competitive options, faster quoting, and a better overall fit for customers' needs and bu

    4/23/26 9:05:00 AM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    Keurig Dr Pepper Reports Q1 Results and Reaffirms Guidance for 2026

    Q1 Performance Led by Strong Momentum in U.S. Refreshment BeveragesCompany Completed Acquisition of JDE Peet's on April 1Company Reaffirms 2026 Constant Currency Net Sales and Adjusted EPS OutlookBURLINGTON, Mass. and FRISCO, Texas, April 23, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP) today reported results for the first quarter of 2026 and reaffirmed its full year guidance.Reported GAAP BasisAdjusted Basis1Q1Q1Net Sales$3.98 bn$3.98 bn% vs prior year9.4 %8.1 %Diluted EPS$0.20$0.39% vs prior year(47.4) %(7.1) %Commenting on the results, CEO Tim Cofer stated, "The year is off to a good start. We delivered a solid first quarter, with strong momentum in our cold beverage portfolio

    4/23/26 7:00:00 AM ET
    $KDP
    Beverages (Production/Distribution)
    Consumer Staples

    La Rosa Holdings Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

    Celebration, FL , April 22, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ:LRHC) ("La Rosa" or the "Company"), a real estate and PropTech enterprise, today announced that on April 16, 2026, it received a delinquency notification letter from the Listing Qualifications Staff of the Nasdaq Stock Market LLC ("Nasdaq") due to the Company's non-compliance with Nasdaq Listing Rule 5250(c)(1) (the "Nasdaq Listing Rule") as a result of the Company's failure to timely file its Annual Report on Form 10-K for the period ended December 31, 2025 (the "Filing"). The Nasdaq Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchan

    4/22/26 8:00:00 AM ET
    $LRHC
    Real Estate
    Finance

    $DPRO
    $GBNH
    $KDP
    $LRHC
    SEC Filings

    View All

    La Rosa Holdings Corp. filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

    8-K - La Rosa Holdings Corp. (0001879403) (Filer)

    4/24/26 5:28:37 PM ET
    $LRHC
    Real Estate
    Finance

    SEC Form DEFA14A filed by Keurig Dr Pepper Inc.

    DEFA14A - Keurig Dr Pepper Inc. (0001418135) (Filer)

    4/24/26 4:15:12 PM ET
    $KDP
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form DEF 14A filed by Keurig Dr Pepper Inc.

    DEF 14A - Keurig Dr Pepper Inc. (0001418135) (Filer)

    4/24/26 4:12:39 PM ET
    $KDP
    Beverages (Production/Distribution)
    Consumer Staples

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Keurig Dr Pepper upgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane upgraded Keurig Dr Pepper from Underperform to Neutral and set a new price target of $28.00

    4/22/26 7:43:24 AM ET
    $KDP
    Beverages (Production/Distribution)
    Consumer Staples

    Rivian Automotive upgraded by DA Davidson with a new price target

    DA Davidson upgraded Rivian Automotive from Underperform to Neutral and set a new price target of $14.00

    4/1/26 9:04:14 AM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Needham reiterated coverage on Draganfly with a new price target

    Needham reiterated coverage of Draganfly with a rating of Buy and set a new price target of $12.00 from $14.00 previously

    3/25/26 1:23:08 PM ET
    $DPRO
    Aerospace
    Industrials

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Leadership Updates

    Live Leadership Updates

    View All

    Draganfly Reports Record Q4 and Year End Results

    Saskatoon, SK., March 24, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO) (CSE:DPRO) (FSE: 3U8A) ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce its fourth quarter and fiscal 2025 financial results. Revenue for the fourth quarter was up 18.5% year over year. Total 2025 revenue increased 17.8%. Key Financial Highlights for 2025: ‎Total revenue for the year ended December 31, 2025, was $7,731,163, an increase of 17.8% from the prior year. Product sales increased $1,501,339, from $5,368,476 in 2024 to $6,869,815 in 2025, an increase of 28.0% year over year. Services revenue decreased $331,231or 27.7% from

    3/24/26 4:46:00 PM ET
    $DPRO
    Aerospace
    Industrials

    Draganfly Demonstrates Advanced Drone Capabilities for Canadian Armed Forces Following MINERVA Working Group Participation

    OTTAWA, ON, March 16, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ:DPRO, CSE:DPRO, FSE: 3U8A)) ("Draganfly" or the "Company"), an award-winning, industry-leading developer of drone solutions and systems, today announced the successful completion of an exclusive Canadian Armed Forces (CAF) capabilities demonstration held on March 11 at Area XO in Ottawa, Ontario. The demonstration was conducted in response to operational capability areas identified through the Canadian Army's MINERVA Uncrewed Aircraft Systems working group, an initiative focused on accelerating the integration of drone and autonomous technologies into future Canadian Armed Forces operations. The demonstration follows D

    3/16/26 8:30:00 AM ET
    $DPRO
    Aerospace
    Industrials

    Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer

    WILMETTE, Ill., March 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (NASDAQ:MNPR) ("Monopar" or the "Company"), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the appointment of Susan Rodriguez as Chief Commercial and Strategy Officer, effective immediately. In this newly created executive role, Ms. Rodriguez will lead the Company's commercial strategy and infrastructure build-out as Monopar prepares for the planned submission of a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") in the first half of 2026 for ALXN1840, its late-stage investigational therapy for Wilson d

    3/2/26 8:00:00 AM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Monopar Therapeutics Inc.

    SC 13D/A - Monopar Therapeutics (0001645469) (Subject)

    12/17/24 5:01:42 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Root Inc.

    SC 13G/A - Root, Inc. (0001788882) (Subject)

    11/14/24 5:46:13 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    Amendment: SEC Form SC 13G/A filed by Draganfly Inc.

    SC 13G/A - Draganfly Inc. (0001786286) (Subject)

    11/14/24 4:02:14 PM ET
    $DPRO
    Aerospace
    Industrials

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Financials

    Live finance-specific insights

    View All

    Keurig Dr Pepper Reports Q1 Results and Reaffirms Guidance for 2026

    Q1 Performance Led by Strong Momentum in U.S. Refreshment BeveragesCompany Completed Acquisition of JDE Peet's on April 1Company Reaffirms 2026 Constant Currency Net Sales and Adjusted EPS OutlookBURLINGTON, Mass. and FRISCO, Texas, April 23, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP) today reported results for the first quarter of 2026 and reaffirmed its full year guidance.Reported GAAP BasisAdjusted Basis1Q1Q1Net Sales$3.98 bn$3.98 bn% vs prior year9.4 %8.1 %Diluted EPS$0.20$0.39% vs prior year(47.4) %(7.1) %Commenting on the results, CEO Tim Cofer stated, "The year is off to a good start. We delivered a solid first quarter, with strong momentum in our cold beverage portfolio

    4/23/26 7:00:00 AM ET
    $KDP
    Beverages (Production/Distribution)
    Consumer Staples

    Root, Inc. Schedules Conference Call to Discuss First Quarter 2026 Financial Results

    COLUMBUS, Ohio, April 16, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ:ROOT), the leading technology company in car insurance, today announced its plans to host a conference call on Wednesday, May 6, 2026 at 5:00 p.m. Eastern Time to discuss financial results for the first quarter 2026 and provide an update on company operations. The company plans to release its first quarter results in the Investor Relations section of its website at ir.joinroot.com following the close of the financial markets on Wednesday, May 6, 2026. Webcast and Conference Call Details: Date: May 6, 2026Time: 5:00 p.m. Eastern TimeParticipant Toll-Free Dial-In Number: 1 (877) 269-7751 Webcast: https://ir.joinroot.com

    4/16/26 4:30:00 PM ET
    $ROOT
    Property-Casualty Insurers
    Finance

    La Rosa Holdings Acquires Remaining 49% Interest in Orlando Brokerage Generating Approximately $3.3 Million in Revenue for 2025

    Celebration, FL, April 15, 2026 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ:LRHC) ("La Rosa" or the "Company"), a real estate and PropTech enterprise, today announced that it has acquired the remaining 49% ownership interest in its franchisee, La Rosa Realty Orlando LLC ("LRRO"). With this transaction, LRRO is now a wholly owned subsidiary of La Rosa. Operating in Orlando, Florida, LRRO generated approximately $3.3 million in revenue and gross profit of over $0.3 million for 2025. The brokerage provides residential and commercial real estate services and offers coaching and support services to agents on a fee basis. Joe La Rosa, CEO of La Rosa, commented, "This acquisition represe

    4/15/26 8:00:00 AM ET
    $LRHC
    Real Estate
    Finance

    $DPRO
    $GBNH
    $KDP
    $LRHC
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Monopar Therapeutics Inc. on Jun 21 Indicate?

    Monopar Therapeutics Inc. has recently seen notable insider activity, with Chief Operating Officer Cittadine Andrew purchasing $25,574 worth of shares on June 21st, 2024. This purchase, comprising 32,508 units at $0.79, increased Cittadine's direct ownership by 21% to 186,132 units as reported in the SEC Form 4. When analyzing this transaction alongside other recent insider activities within the company, interesting patterns and trends start to emerge. Looking back, Cittadine Andrew has been consistently adding to his position in Monopar Therapeutics Inc. over the past few months, showcasing a strong conviction in the company's future prospects. On May 31st, Cittadine Andrew made a substan

    6/22/24 8:00:00 PM ET
    $MNPR
    Biotechnology: Pharmaceutical Preparations
    Health Care